In breast cancer (BC) patients treated with anthracyclines-based therapies, we aim at assessing whether adjuvant drugs impact cardiac function differently and whether their cardiotoxicity has a regional pattern.
Anthracyclines and regional myocardial damage in breast cancer patients. A multicentre study from the Working Group on Drug Cardiotoxicity and Cardioprotection, Italian Society of Cardiology (SIC)
Cadeddu Dessalvi, Christian;Deidda, Martino;
2021-01-01
Abstract
In breast cancer (BC) patients treated with anthracyclines-based therapies, we aim at assessing whether adjuvant drugs impact cardiac function differently and whether their cardiotoxicity has a regional pattern.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Zito EurHJ Card.Imaging 2021.pdf
Solo gestori archivio
Tipologia:
versione post-print (AAM)
Dimensione
487.6 kB
Formato
Adobe PDF
|
487.6 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
